Fundraising FoxVeriskin
San Diego, US · Founded 2016 · Delaware corporation · 2 known investors
Find your way into Veriskin
Sign up to see every warm intro you have to Veriskin
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Veriskin team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Veriskin makes a handheld, AI-powered medical device that assesses suspect skin growths by imaging cutaneous blood flow in real time, delivering results in about two minutes. It is aimed at clinical skin cancer screening, supporting early detection while reducing false positives and referrals.
Founders & leadership
Investors · 2
Reported raises · per SEC filings
Form D private placements$682.3K disclosed across 1 round · 2020
▶$682.3KraisedNov 2020 · 22 investors · BiotechnologyRule 506(b)
- Kevin HerzbergDirector
- John FitzgibbonDirector
- Eugene TuDirector
- Mirianas ChachisvilisExecutive Officer, Director
- Carl EdmanDirector
- Offering amount
- $1.5M
- Amount sold
- $682.3K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.9M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Veriskin do?
- Veriskin makes a handheld, AI-powered medical device that assesses suspect skin growths by imaging cutaneous blood flow in real time, delivering results in about two minutes. It is aimed at clinical skin cancer screening, supporting early detection while reducing false positives and referrals.
- Who are Veriskin's investors?
- Veriskin's investors include Arieal Southeast Angel Partners, Pasadena Angels.
- How much funding has Veriskin raised?
- Veriskin has disclosed $682.3K raised across 1 round.
- Where is Veriskin headquartered?
- Veriskin is headquartered in San Diego, US.